Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23309507 | 0.82 | NPC1 (0.57) | ALDH1A1RAB9AL3MBTL1MEN1KMT2A | |
| SCHEMBL23309556 | 0.80 | F2 (0.35) | MAOAMAOBMAPTTDP1KMT2A | |
| SCHEMBL23309730 | 0.79 | KMT2A (0.47) | ALDH1A1MAOAMAOBRAB9ALMNA | |
| SCHEMBL23309490 | 0.78 | GAA (0.51) | ALDH1A1MAOAMAOBRAB9ALMNA | |
| SCHEMBL23309488 | 0.78 | CYP1A2 (0.52) | ALDH1A1RAB9ALMNAL3MBTL1POLB | |
| SCHEMBL23309555 | 0.77 | HTT (0.55) | RAB9AHTTL3MBTL1NPC1 | |
| SCHEMBL23309628 | 0.77 | SIRT2 (0.46) | MAOAMAOBSIRT2RAB9AMEN1 | |
| SCHEMBL23309532 | 0.77 | RAB9A (0.51) | ALDH1A1SIRT2RAB9AMAPTKMT2A | |
| SCHEMBL23309502 | 0.75 | NFKB1 (0.51) | ALDH1A1MAOBRAB9AHTTPOLB | |
| SCHEMBL23309725 | 0.75 | GAA (0.43) | ALDH1A1MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | BROX, ALG1, CTRL | ALDH1A1 2033/4885MAOA 1498/4885MAOB 2341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.